Ares Commercial Real Estate Corp (ACRE) concluded trading on Wednesday at a closing price of $4.83, with 0.47 million shares of worth about $2.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -32.82% during that period and on June 18, 2025 the price saw a gain of about 0.42%. Currently the company’s common shares owned by public are about 54.86M shares, out of which, 51.00M shares are available for trading.
Stock saw a price change of -4.36% in past 5 days and over the past one month there was a price change of -1.43%. Year-to-date (YTD), ACRE shares are showing a performance of -18.00% which decreased to -31.78% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.35 but also hit the highest price of $7.99 during that period. The average intraday trading volume for Ares Commercial Real Estate Corp shares is 582.02K. The stock is currently trading 1.74% above its 20-day simple moving average (SMA20), while that difference is up 9.91% for SMA50 and it goes to -15.40% lower than SMA200.
Ares Commercial Real Estate Corp (NYSE: ACRE) currently have 54.86M outstanding shares and institutions hold larger chunk of about 43.02% of that.
The stock has a current market capitalization of $265.68M and its 3Y-monthly beta is at 1.36. It has posted earnings per share of -$0.25 in the same period. It has Quick Ratio of 0.80 while making debt-to-equity ratio of 1.74. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACRE, volatility over the week remained 1.42% while standing at 1.93% over the month.
Stock’s fiscal year EPS is expected to rise by 102.58% while it is estimated to increase by 989.01% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on September 20, 2024 offering an Underweight rating for the stock and assigned a target price range of between $7.50 and $7 to it. On March 04, 2024, BofA Securities Downgrade their recommendations, while on December 06, 2023, UBS Initiated their ratings for the stock with a price target of $10.50. Stock get a Mkt perform rating from JMP Securities on December 05, 2023.
